Applications of DNA integrating elements: Facing the bias bully
- PMID: 26442173
- PMCID: PMC4588226
- DOI: 10.4161/2159256X.2014.992694
Applications of DNA integrating elements: Facing the bias bully
Abstract
Retroviruses and DNA transposons are an important part of molecular biologists' toolbox. The applications of these elements range from functional genomics to oncogene discovery and gene therapy. However, these elements do not integrate uniformly across the genome, which is an important limitation to their use. A number of genetic and epigenetic factors have been shown to shape the integration preference of these elements. Insight into integration bias can significantly enhance the analysis and interpretation of results obtained using these elements. For three different applications, we outline how bias can affect results, and can potentially be addressed.
Keywords: chromatin position effect; epigenomics; gene therapy; insertional mutagenesis; integration bias.
Figures
Similar articles
-
Integration site selection by retroviruses and transposable elements in eukaryotes.Nat Rev Genet. 2017 May;18(5):292-308. doi: 10.1038/nrg.2017.7. Epub 2017 Mar 13. Nat Rev Genet. 2017. PMID: 28286338 Review.
-
Structure-based prediction of insertion-site preferences of transposons into chromosomes.Nucleic Acids Res. 2006 May 22;34(9):2803-11. doi: 10.1093/nar/gkl301. Print 2006. Nucleic Acids Res. 2006. PMID: 16717285 Free PMC article.
-
Chromatin states shape insertion profiles of the piggyBac, Tol2 and Sleeping Beauty transposons and murine leukemia virus.Sci Rep. 2017 Mar 2;7:43613. doi: 10.1038/srep43613. Sci Rep. 2017. PMID: 28252665 Free PMC article.
-
The use of DNA transposons for cancer gene discovery in mice.Methods Enzymol. 2010;477:91-106. doi: 10.1016/S0076-6879(10)77006-3. Methods Enzymol. 2010. PMID: 20699138
-
Integration _target site selection for retroviruses and transposable elements.Cell Mol Life Sci. 2004 Oct;61(19-20):2588-96. doi: 10.1007/s00018-004-4206-9. Cell Mol Life Sci. 2004. PMID: 15526164 Review.
Cited by
-
Integration site selection by retroviruses and transposable elements in eukaryotes.Nat Rev Genet. 2017 May;18(5):292-308. doi: 10.1038/nrg.2017.7. Epub 2017 Mar 13. Nat Rev Genet. 2017. PMID: 28286338 Review.
-
Transmicron: accurate prediction of insertion probabilities improves detection of cancer driver genes from transposon mutagenesis screens.Nucleic Acids Res. 2023 Feb 28;51(4):e21. doi: 10.1093/nar/gkac1215. Nucleic Acids Res. 2023. PMID: 36617985 Free PMC article.
-
Prolonged activity of the transposase helper may raise safety concerns during DNA transposon-based gene therapy.Mol Ther Methods Clin Dev. 2023 Mar 14;29:145-159. doi: 10.1016/j.omtm.2023.03.003. eCollection 2023 Jun 8. Mol Ther Methods Clin Dev. 2023. PMID: 37025950 Free PMC article.
References
-
- Bouwman P, Aly A, Escandell JM, Pieterse M, Bartkova J, van der Gulden H, Hiddingh S, Thanasoula M, Kulkarni A, Yang Q, et al. . 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat Struct & Mol Biol 2010; 17:688-95; PMID:20453858; http://dx.doi.org/10.1038/nsmb.1831 - DOI - PMC - PubMed
-
- Miller EH, Obernosterer G, Raaben M, Herbert AS, Deffieu MS, Krishnan A, Ndungo E, Sandesara RG, Carette JE, Kuehne AI, et al. . Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J 2012; 31(8):1947-60; PMID:22395071; doi:10.1038/emboj.2012.53 - DOI - PMC - PubMed
-
- Kool J, Uren AG, Martins CP, Sie D, de Ridder J, Turner G, van Uitert M, Matentzoglu K, Lagcher W, Krimpenfort P, et al. . Insertional mutagenesis in mice deficient for p15Ink4b, p16Ink4a, p21Cip1, and p27Kip1 reveals cancer gene interactions and correlations with tumor phenotypes. Cancer Res 2010; 70:520-31; PMID:20068150; http://dx.doi.org/10.1158/0008-5472.CAN-09-2736 - DOI - PMC - PubMed
-
- Mattison J, Kool J, Uren AG, de Ridder J, Wessels L, Jonkers J, Bignell GR, Butler A, Rust AG, Brosch M, et al. . Novel candidate cancer genes identified by a large-scale cross-species comparative oncogenomics approach. Cancer Res 2010; 70:883-95; PMID:20103622; http://dx.doi.org/10.1158/0008-5472.CAN-09-1737 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources